Sponsor Team Osbon

John Osbon - March 12, 2013

In about four months my son Max and I will proudly take the field at Columbia University’s Wien Stadium for The RBC Decathlon where we’ll give it our all for the benefit of Memorial Sloan-Kettering Cancer Center.

We’re excited for the event and ramping up our training. But we need your help. Since you won’t be able to help us complete the bench press, agility course or 40 yard dash, we’d like to request your financial support. Will you sponsor us? 

Ten events; one great cause

As I described in an earlier post, the field is composed of 150 of the fittest, fastest, strongest, and most competitive guys and gals in the financial industry. We’ll compete in ten events: a 400 meter run, football throw, pull-ups, vertical jump, 500 meter row, 800 meter run, agility drill, dips, 175 pound bench press, and 40 yard dash.

The 11th event is fundraising, one that everyone wins. Event sponsors hope to raise $2 million for Memorial Sloan-Kettering this year, about 50% more than last year. We want to be a big part of that, and ask for your help.

Get in on the games

One of the unique aspects of The RBC Decathlon is its “CharityBets” fundraising system. You basically make a bet on our performance – the better we do, the more you contribute.

For instance, I’ve set a goal of 90 seconds for the 400 meter run, a worthy target for my age group. If I beat the goal, your donation increases, capped at 200% of your bet. If I fall short, you save some money.

Likewise, Max has set a goal of 2:35 for the 800 meter run. Oh to be young. The faster he goes, the more financial support for MSKCC.

Of course you can also make a flat dollar amount donation. We appreciate your support and will do our best to represent! It’s sure to be fun, especially when we finish the last of our events! Thanks!

Sponsor John Osbon

Sponsor Max Osbon

Memorial Sloan-Kettering Cancer Center is one of the leading pediatric cancer institutes, committed to providing patients with the best care available today as they work to discover more effective strategies to prevent, control, and ultimately cure cancer in the future.

Print Friendly, PDF & Email

Disclaimer

  • This communication may include forward-looking statements. All statements other than statements of historical fact are forward-looking statements (including words such as “believe,” “estimate,” “anticipate,” “may,” “will,” “should,” and “expect”). Although we believe that the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct. Various factors could cause actual results or performance to differ materially from those discussed in such forward-looking statements.”
  • “Historical performance is not indicative of future results. The investment return will fluctuate with market conditions.
  • Past performance is not indicative of any specific investment or future results. Views regarding the economy, securities markets or other specialized areas, like all predictors of future events, cannot be guaranteed to be accurate and may result in economic loss to the investor.
  • Investment strategies, philosophies, allocations and holdings are subject to change without prior notice.
  • This communication is intended to provide general information only and should not be construed as an offer of specifically tailored individualized advice.
  • While the Adviser believes the outside data sources cited to be credible, it has not independently verified the correctness of any of their inputs or calculations and, therefore, does not warranty the accuracy of any third-party sources or information.
  • Adviser does not endorse the statements, services or performance of any third-party vendor.
  • Unless stated otherwise, any mention of specific securities or investments is for hypothetical and illustrative purposes only. Adviser’s clients may or may not hold the securities discussed in their portfolios. Adviser makes no representations that any of the securities discussed have been or will be profitable.